Price to Sales ratio Analysis of Eagle Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PS
Period Ending - Dec-22
Excellent PS
0.143
Period Ending - Dec-21
Excellent PS
0.265
Growth
-45.87 %
Trailing Twelve Months PS
Period Ending - Dec-22
Excellent PS
0.119
PS Analysis of Eagle Pharmaceuticals Inc
| P/S Ratio 0.119 of Eagle Pharmaceuticals Inc indicates that stock price is low compared to sales of the company and may be undervalued. |
| PS Ratio of EGRX drastically fell by -45.87 % this year. |
| PS Ratio with value of 0.265 was highest in Year Dec-21 in last Five Years. |
| PS Ratio with value of 0.143 was lowest in Year Dec-22 in last Five Years. |
| Latest PS Ratio with value of 0.143 is lower than Average PS of 0.232 in last five years. |
Other PS Related Info of EGRX that may interest you.
Eagle Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| EGRX | 3.47 | 3.425 | 1.31 % | Drug Manufacturers-Specialty & Generic |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..
PS Related Ratios
| PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
| Good Value | |
FY - Historical Price to Sales of Eagle Pharmaceuticals Inc
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|
| PS | 0.143 | 0.265 | 0.254 | 0.250 | 0.249 | 0.233 | 0.301 |
| Change | -45.87 % | 3.96 % | 1.60 % | 0.768 % | 6.58 % | -22.51 % | -64.66 % |
FY Chart of Price to Sales of Eagle Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)